At Galderma, we embrace these differences and offer cutting-edge, premium brands that fit people's individual needs, across the full spectrum of dermatology through Injectable …

Galderma is the pure-play dermatology category leader, committed to advancing dermatology for every skin story. Leveraging our unique 40-year heritage of leading science-based innovation, …

Relfydess ® (RelabotulinumtoxinA) is the first and only ready-to-use liquid neuromodulator created with PEARL TM Technology, developed and manufactured by Galderma. Relfydess ® …

Galderma is the leading company solely dedicated to the human body’s largest organ: the skin. We are strategically positioned in resilient, highly attractive and consumer-focused sub …

Galderma is the leading dermatology company for consumers, patients and healthcare professionals. We deliver an innovative, science-based portfolio of sophisticated brands and …

The mission of Galderma is to enhance people’s quality of life and contribute to a healthier future through science-based solutions for skin health.

This product is under investigation as a novel, ready-to-use, liquid formulation of botulinum neuromodulator for the treatment of glabellar lines and lateral canthal lines. In 2023, results …

Galderma is the only truly scaled pure-play dermatology company. Our 40+ year heritage in dermatology; premium portfolio of brands and services; and positioning in attractive market …

Galderma is committed to supporting the medical community and advancing the science of skin health to address patients’ needs. We do this in a variety of ways, including the support of …

For over 35 years, Galderma has partnered with healthcare professionals and academia across the globe to find innovative solutions to skin issues and deliver safe and effective treatments to …